Neuropathology Core
神经病理学核心
基本信息
- 批准号:10385833
- 负责人:
- 金额:$ 28.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-05-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer disease preventionAlzheimer&aposs DiseaseAlzheimer&aposs disease diagnosisArchivesAutopsyBiological AssayBiological MarkersBloodBlood VesselsBrainBrain regionCatalogingCatalogsCell LineCellsCellular biologyCessation of lifeClinicalClinical DataCollaborationsCollectionCommunicationCountryDNADataDatabasesDementiaDiagnosisDiagnosticDisease ProgressionElderlyElementsEnrollmentEnsureEvaluationFamilyFreezingGeneticGenetic MarkersGenomicsGoalsIndividualInternationalInternetLeadershipLewy BodiesLifeLinkMemoryMissionMolecularMolecular AnalysisMonitorMorphologyNeurosciencesParticipantPathologicPathologyPatientsProcessProteomicsRegistriesResearchResearch PersonnelResearch Project GrantsResourcesRiskRoleSamplingServicesSpecimenStem Cell ResearchTechnologyTimeTissue BanksTissuesTrainingTranslational ResearchUniversitiesVeinsWisconsinblood productcell bankcell repositoryclinical biomarkersclinical carecohortdata managementdisorder controlexperienceinduced pluripotent stem cellinnovationinterestmild cognitive impairmentneuroimagingneuroimaging markerneuropathologynormal agingnovel markerpre-clinicalprogramsprotein TDP-43repositorysoftware developmentstem cellssymposiumtissue biomarkerstool
项目摘要
PROJECT SUMMARY - NEUROPATHOLOGY CORE (CORE D)
The mission of the Neuropathology Core at the Wisconsin Alzheimer's Disease Research Center (ADRC) is to:
provide detailed characterization of brains from patients with Alzheimer's disease (AD) and other dementias;
facilitate scientific and intellectual interactions between the various ADRC cores; and serve as a local and
national repository for AD specimens. The Core will continue to facilitate clinical-pathologic and translational
research on normal aging, mild cognitive impairment (MCI), AD, and other dementias by providing to Wisconsin
ADRC and outside investigators a comprehensive resource of biospecimens, biomarker data, clinical data, and
state-of-the-art diagnoses for MCI and AD, vascular, Lewy body, TDP-43, and mixed pathologies, from subjects
in the Clinical Core and Wisconsin Registry for Alzheimer's Prevention (WRAP). The Neuropathology Core will
generate and assemble critical diagnostic information by combining clinical data (Core B), innovative
neuroimaging and biomarker assays (Core G) collected during life with brain autopsy, and morphologic,
immunohistochemical, genetic, cell and molecular post-mortem analyses. The Neuropathology Core will also
provide access to cutting edge tools (including genomics and proteomics) to enhance AD research on banked,
frozen tissue. Additionally, the Core has taken a leadership role in setting up an induced pluripotent stem cells
(iPSC) bank, with the aim of providing well-characterized stem cell lines from AD and control patients to
investigators throughout the country. The Core will accomplish these goals by 1) collecting and archiving post-
mortem frozen and fixed tissue blocks from multiple brain regions on deceased individuals, and ante-mortem
CSF, blood, and DNA who are enrolled in the Wisconsin ADRC as well as normal elderly controls; 2) providing
state-of-the-art postmortem diagnoses on Clinical Core subjects, collect National Alzheimer's Coordinating
Center (NACC) neuropathology data and make the results available to the family, relevant clinicians, qualified
researchers, and NACC; 3) distributing ante-mortem and post-mortem biospecimens (brain, CSF, blood
products, and DNA) and neuropathologic, genetic, biomarker, and other data to suit the requirements of qualified
research projects, both within UW-Madison and for national and international multi-center collaborations; 4)
performing genetic and biomarker analyses in support of ADRC and outside investigators; and 5) providing well-
characterized iPSC lines to local and national researchers. A flow of services is therefore envisaged whereby
Wisconsin ADRC investigators and collaborators are able to obtain unambiguous post-mortem diagnosis,
neuropathological data, and tissues from the Neuropathology Core together with comprehensive biomarker data
(Biomarker Services) and neuroimaging data (Core G). Finally, the Core will also support advanced molecular
and cellular analyses can be performed on tissues by the Biomarker and Cellular and Molecular Neuroscience
Services.
项目总结-神经病理学核心(核心d)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas J Montine其他文献
Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated α-synuclein
- DOI:
10.1186/1742-2094-4-2 - 发表时间:
2007-01-04 - 期刊:
- 影响因子:10.100
- 作者:
Jinghua Jin;Feng-Shiun Shie;Jun Liu;Yan Wang;Jeanne Davis;Aimee M Schantz;Kathleen S Montine;Thomas J Montine;Jing Zhang - 通讯作者:
Jing Zhang
Thomas J Montine的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas J Montine', 18)}}的其他基金
Project 2: Particle and brain mapping of CSF proteins using elemental reporters with mass spectrometry
项目 2:使用元素报告仪和质谱法对 CSF 蛋白进行粒子和脑图谱分析
- 批准号:
10359193 - 财政年份:2020
- 资助金额:
$ 28.75万 - 项目类别:
Project 2: Particle and brain mapping of CSF proteins using elemental reporters with mass spectrometry
项目 2:使用元素报告仪和质谱法对 CSF 蛋白进行粒子和脑图谱分析
- 批准号:
10573262 - 财政年份:2020
- 资助金额:
$ 28.75万 - 项目类别: